MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 73 filers reported holding MINERVA NEUROSCIENCES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,976,000 | +37.6% | 255,000 | 0.0% | 0.04% | +48.1% |
| Q2 2019 | $1,436,000 | -28.3% | 255,000 | 0.0% | 0.03% | -30.8% |
| Q1 2019 | $2,004,000 | +45.0% | 255,000 | +24.4% | 0.04% | +39.3% |
| Q4 2018 | $1,382,000 | -46.3% | 205,000 | 0.0% | 0.03% | -12.5% |
| Q3 2018 | $2,573,000 | +149.6% | 205,000 | +64.0% | 0.03% | +60.0% |
| Q2 2018 | $1,031,000 | -13.2% | 125,000 | -34.2% | 0.02% | +66.7% |
| Q1 2018 | $1,188,000 | +3.3% | 190,000 | 0.0% | 0.01% | -14.3% |
| Q4 2017 | $1,150,000 | -20.4% | 190,000 | 0.0% | 0.01% | -22.2% |
| Q3 2017 | $1,444,000 | +87.5% | 190,000 | +100.0% | 0.02% | -14.3% |
| Q1 2017 | $770,000 | -6.3% | 95,000 | +35.7% | 0.02% | -16.0% |
| Q4 2016 | $822,000 | -16.8% | 70,000 | 0.0% | 0.02% | -13.8% |
| Q3 2016 | $988,000 | +93.7% | 70,000 | +40.0% | 0.03% | +38.1% |
| Q2 2016 | $510,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,652,436 | $31,166,000 | 4.20% |
| NEXTHERA CAPITAL LP | 492,958 | $5,792,000 | 3.40% |
| Iguana Healthcare Management, LLC | 150,000 | $1,763,000 | 1.05% |
| Perceptive Advisors | 810,537 | $9,523,000 | 0.68% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,141,333 | $13,411,000 | 0.63% |
| FEDERATED HERMES, INC. | 6,358,642 | $74,714,000 | 0.22% |
| EAM Investors, LLC | 137,685 | $1,618,000 | 0.22% |
| Orbimed Advisors | 556,200 | $6,535,000 | 0.08% |
| J. Goldman & Co LP | 103,281 | $1,214,000 | 0.08% |
| Virtus ETF Advisers LLC | 18,814 | $221,000 | 0.07% |